Notable Friday Option Activity: BX, RRC, HCA

Range Resources saw unusually large options activity with 15,586 contracts traded today (≈1.6M underlying shares), equal to about 46.6% of its one‑month ADTV of 3.3M shares; the most active instrument was the $40 call expiring March 20, 2026 (8,597 contracts, ≈859,700 shares). HCA Healthcare recorded 6,232 option contracts (≈623,200 underlying shares), about 45% of its one‑month ADTV of 1.4M shares, led by a $475 put expiring December 19, 2025 (1,195 contracts, ≈119,500 shares). The flows indicate concentrated positioning in single strikes for both names but are reported as trade‑flow data rather than corporate or fundamental developments.

Analysis

Market structure: The outsized RRC Mar‑20‑2026 $40 call flow (8,597 contracts ≈ 860k shares, ~46% of ADV) is a concentrated bullish positioning event that will force market‑makers to delta‑hedge (buy stock) into whatever liquidity exists over days–weeks, creating asymmetric short‑term upward pressure on RRC shares and compressing implied volatility on longer‑dated calls if sustained. Conversely the HCA Dec‑19‑2025 $475 put block (1,195 contracts ≈ 120k shares, ~45% of ADV) signals concentrated downside hedging/speculation that will raise put skew and IV on HCA and can accelerate downside via gamma flows. Cross‑asset: RRC flows may have second‑order links to nat‑gas forward curves (producer sentiment), while HCA flow can increase credit spread sensitivity for hospital bond paper and push healthcare sector IV higher for 1–3 months.

Risk assessment: Immediate risk (days) is a gamma squeeze/unwind: rapid moves could overshoot by ±10–20% intraday relative to fair value; short‑term (weeks–months) risk is IV repricing if these are hedge trades rather than directional bets. Tail risks include mistaken interpretation (block is sell‑to‑open by a dealer), regulatory surprise for healthcare reimbursement or a commodity shock for gas that invalidates options-based positioning, each capable of >30% move. Hidden dependencies: large blocks may be collars, institutional balance‑sheet hedges, or arbitrage trades tied to convertible issuance — verify trade side and clearing codes; key catalysts are upcoming earnings, nat‑gas storage prints, and expiration dates (Dec‑2025, Mar‑2026).

Trade implications: For RRC, prefer defined‑risk bullish exposure (buy call spreads or 1–2% equity exposure) to capture potential gamma‑driven lift while limiting theta decay; consider buy Apr/Oct 2026 $35/$45 call spreads sized to 1–2% NAV, trim at +30–50% or if RRC rises >15% in 10 trading days. For HCA, use protective/vertical put spreads (Dec‑2025 $450/$475 or similar) or a small (1%) short equity position funded by selling OTM calls if IV >30% — cap loss at 12% and add if IV spikes >25% and price drops >8%. Sector: rotate modestly (3–5% reweight) from large hospital operators into select E&P midcaps if commodity outlook improves.

Key Decisions for Investors

• Establish a 1–2% portfolio position in RRC via a defined‑risk long call spread (Mar‑20‑2026 $35/$45 or nearest strikes) within 5 trading days to capture gamma/dealer hedging; set a trim target at +30–50% or if RRC rallies >15% within 10 trading days, stop‑loss at 12% of premium.
• Enter a tactical bearish/hedge position on HCA sized 1% NAV by buying a Dec‑19‑2025 put spread (e.g., $450/$475) or shorting 0.5–1% equity funded by selling a near‑OTM covered call; reduce or exit if implied vol on HCA drops >15% or price recovers >8% from entry within 30 days.
• Implement a 3–5% sector rotation: trim 3% exposure to large hospital operators (HCA, HUM) and redeploy into energy midcaps including RRC and two other active natural‑gas producers over the next 2–6 weeks if nat‑gas front‑month futures hold >$3.50/MMBtu, otherwise pause redeployment.
• Before scaling beyond suggested sizes, confirm trade side via block prints/clearing data (within 48 hours) and monitor IV and open interest: if RRC call IV falls >20% or HCA put IV rises >25% from today's print, reprice and adjust position sizes down 30–50%.